Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Somnolence	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
with	O
history	O
of	O
HFpEF,	O
HTN,	O
CLL,	O
and	O
progressive	O
dementia	B-Dementia
presenting	O
with	O
SOB	O
and	O
fatigue	O
that	O
has	O
been	O
worsening	O
over	O
past	O
several	O
days.	O
Patient	O
has	O
associated	O
non-productive	O
cough.	O
Denies	O
fevers	O
and	O
chills.	O
One	O
episode	O
of	O
diarrhea	O
yesterday	O
(___).	O
Patient	O
was	O
seen	O
by	O
PCP	O
___	O
(___)	O
and	O
note	O
in	O
chart	O
reports	O
patient	O
has	O
been	O
having	O
increased	O
confusion,	B-Delirium
not	O
at	O
baseline.	O
According	O
to	O
note	O
he	O
is	O
at	O
baseline	O
weight	O
of	O
205lbs.	O
They	O
have	O
been	O
concerned	O
about	O
diastolic	O
CHF	O
he	O
takes	O
40mg	O
of	O
torsemide	O
daily.	O
Of	O
note	O
patients	O
glyburide	O
dosage	O
has	O
recently	O
been	O
increased	O
to	O
7.5	O
mg	O
daily.	O
Per	O
the	O
DTR,	O
Patient	O
has	O
had	O
a	O
"bad	O
cold"	O
with	O
nonproductive	O
cough,	O
hoarse	O
voice,	O
rhonorrhea	O
but	O
no	O
fevers	O
for	O
the	O
past	O
week	O
and	O
was	O
evaluated	O
by	O
___	O
brought	O
him	O
robitussin	O
DM	O
in	O
the	O
last	O
week.	O
Dtr	O
visited	O
him	O
on	O
___	O
found	O
him	O
very	O
weak	O
with	O
poor	O
po	O
intake.	O
Patient	O
has	O
had	O
___	O
swelling	O
for	O
months	O
and	O
they	O
have	O
been	O
wrapping	O
his	O
legs	O
with	O
ace	O
bandages.	O
In	O
the	O
ED	O
daughter	O
reports	O
he	O
is	O
more	O
somnolent	O
now	O
then	O
he	O
was	O
when	O
she	O
had	O
seen	O
him	O
last	O
week.	O
In	O
the	O
ED,	O
initial	O
VS	O
were	O
97.2	O
87	O
127/63	O
16	O
90%	O
on	O
RA	O
and	O
97%	O
4L	O
Labs	O
significant	O
for	O
H/H	O
of	O
10.8/33.6	O
(from	O
___	O
in	O
___,	O
WBC	O
15.3	O
(75.3%PMN),	O
BUN:Cr	O
44/1.7	O
(from	O
___	O
in	O
___.	O
BNP	O
1631	O
(from	O
Imaging	O
significant	O
for	O
___	O
of	O
RLE	O
was	O
negative	O
for	O
DVT,	O
CXR	O
without	O
acute	O
findings	O
and	O
CT	O
head	O
w/o	O
contrast	O
showing	O
no	O
acute	O
process.	O
Received	O
Albuterol	O
neb,	O
1	O
L	O
NS.	O
1	O
gm	O
CTX,	O
and	O
500	O
mg	O
Axithromycin	O
Transfer	O
VS	O
were	O
81	O
112/50	O
17	O
96%	O
Nasal	O
Cannula	O
On	O
arrival	O
to	O
the	O
floor,	O
patient	O
is	O
A+O	B-Delirium
x1	O
is	O
somnulent	O
and	O
unable	O
to	O
state	O
why	O
he	O
came	O
to	O
the	O
hospital.	O
Past	O
Medical	O
History:	O
___	O
___	O
echo	O
with	O
EF	O
>55%)	O
CLL	O
T2DM	O
Hypertension	O
Hyperlipidemia	O
BPH	O
H/o	O
DVT	O
Social	O
History:	O
___	O
Family	O
History:	O
Non-contributory	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
T98.4	O
BP	O
150/95	O
hr	O
62	O
R	O
20	O
97%	O
on	O
3l	O
NC,	O
95	O
%	O
on	O
RA	O
GENERAL:	O
NAD,	O
sleeping	O
comfortably	O
arrousable	O
to	O
yelling/	O
vigorous	O
shaking	O
HEENT:	O
OP	O
dry	O
MMM,	O
left	O
eye	O
with	O
e/o	O
blepharitis	O
no	O
e/o	O
JVD	O
CARDIAC:	O
RRR,	O
S1/S2,	O
no	O
murmurs,	O
gallops,	O
or	O
rubs	O
LUNG:	O
Clear,	O
some	O
upper	O
airway	O
grunting	O
ABDOMEN:	O
obese,	O
mildly	O
distended,	O
+BS,	O
nontender	O
EXTREMITIES:	O
moving	O
all	O
extremities	O
well,	O
trace	O
___	O
edema	O
R>L	O
PULSES:	O
2+	O
DP	O
pulses	O
bilaterally	O
NEURO:	O
follow	O
commands,	O
MAE	O
SKIN:	O
venous	O
stasis	O
changes	O
in	O
___	O
bilaterally	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
Vitals:	O
Tm	O
99.0,	O
125/73,	O
98,	O
20,	O
93%	O
on	O
RA	O
Wt:	O
203.6	O
lbs	O
(___)	O
<-	O
207	O
lbs	O
___,	O
day	O
of	O
admission)	O
GENERAL:	O
NAD,	O
mental	O
status	O
continues	O
to	O
improve,	O
A&Ox3,	B-Delirium
good	O
attention	O
HEENT:	O
Oropharynx	O
wnl,	O
MMM,	O
JVP	O
not	O
elevated	O
CARDIAC:	O
RRR,	O
S1/S2,	O
no	O
murmurs,	O
gallops,	O
or	O
rubs	O
LUNG:	O
Mostly	O
clear	O
to	O
auscultation,	O
minimal	O
bibasilar	O
crackles	O
ABDOMEN:	O
obese,	O
+BS,	O
nontender	O
EXTREMITIES:	O
moving	O
all	O
extremities	O
well,	O
trace	O
edema	O
in	O
LLE,	O
1+	O
edema	O
in	O
RLE	O
PULSES:	O
2+	O
DP	O
pulses	O
bilaterally	O
SKIN:	O
venous	O
stasis	O
changes	O
in	O
___	O
bilaterally	O
Pertinent	O
Results:	O
=====	O
ADMISSION	O
LABS	O
=====	O
___	O
04:15PM	O
BLOOD	O
WBC-15.3*	O
RBC-4.08*	O
Hgb-10.8*	O
Hct-33.6*	O
MCV-82	O
MCH-26.5*	O
MCHC-32.2	O
RDW-15.7*	O
Plt	O
___	O
___	O
04:15PM	O
BLOOD	O
Neuts-75.3*	O
Lymphs-17.8*	O
Monos-5.9	O
Eos-0.6	O
Baso-0.4	O
___	O
08:00AM	O
BLOOD	O
___	O
PTT-28.7	O
___	O
___	O
04:15PM	O
BLOOD	O
Glucose-149*	O
UreaN-44*	O
Creat-1.7*	O
Na-140	O
K-4.2	O
Cl-98	O
HCO3-29	O
AnGap-17	O
___	O
08:00AM	O
BLOOD	O
Calcium-8.3*	O
Phos-3.9	O
Mg-2.1	O
___	O
08:34PM	O
BLOOD	O
Lactate-1.6	O
calHCO3-30	O
=====	O
OTHER	O
PERTINENT	O
LABS	O
======	O
___	O
04:15PM	O
BLOOD	O
proBNP-1631*	O
___	O
12:02AM	O
BLOOD	O
%HbA1c-8.7*	O
eAG-203*	O
___	O
08:00AM	O
BLOOD	O
VitB12-791	O
___	O
08:00AM	O
BLOOD	O
TSH-1.4	O
___	O
07:55AM	O
BLOOD	O
Iron-31*	O
___	O
07:55AM	O
BLOOD	O
calTIBC-250*	O
Ferritn-131	O
TRF-192*	O
=====	O
DISCHARGE	O
LABS	O
=====	O
___	O
07:55AM	O
BLOOD	O
WBC-9.3	O
RBC-3.89*	O
Hgb-10.3*	O
Hct-31.5*	O
MCV-81*	O
MCH-26.5*	O
MCHC-32.8	O
RDW-16.0*	O
Plt	O
___	O
___	O
07:55AM	O
BLOOD	O
Glucose-157*	O
UreaN-27*	O
Creat-1.2	O
Na-141	O
K-4.1	O
Cl-99	O
HCO3-31	O
AnGap-15	O
___	O
07:55AM	O
BLOOD	O
Phos-3.5	O
Mg-2.0	O
=====	O
MICRO	O
=====	O
Urine	O
culture	O
(___):	O
No	O
growth	O
(final)	O
Blood	O
culture	O
(___):	O
No	O
growth	O
as	O
of	O
___	O
=====	O
IMAGING	O
=====	O
ECG	O
(___):	O
Sinus	O
arrhythmia	O
or	O
atrial	O
premature	O
beats.	O
Consider	O
left	O
atrial	O
abnormality.	O
Left	O
anterior	O
fascicular	O
block.	O
Right	O
bundle-branch	O
block.	O
Compared	O
to	O
the	O
previous	O
tracing	O
of	O
___	O
the	O
rate	O
is	O
now	O
faster.	O
ST-T	O
wave	O
abnormality	O
pattern	O
is	O
somewhat	O
different,	O
may	O
be	O
related	O
to	O
rate	O
differences.	O
Clinical	O
correlation	O
is	O
suggested.	O
CXR	O
(___):	O
AP	O
upright	O
and	O
lateral	O
views	O
of	O
the	O
chest	O
provided.	O
Despite	O
low	O
lung	O
volumes,	O
the	O
lungs	O
appear	O
clear.	O
No	O
large	O
effusion	O
or	O
pneumothorax.	O
No	O
convincing	O
signs	O
of	O
edema.	O
Cardiomediastinal	O
silhouette	O
is	O
stable	O
with	O
mild	O
cardiomegaly	O
in	O
an	O
unfolded	O
thoracic	O
aorta.	O
Bony	O
structures	O
are	O
intact.	O
RIGHT	O
LOWER	O
EXTREMITY	O
DOPPLER	O
(___):	O
No	O
evidence	O
of	O
deep	O
venous	O
thrombosis	O
in	O
the	O
right	O
lower	O
extremity	O
veins.	O
CT	B-Intracranial_haemorrhage
HEAD	O
W/O	O
CONTRAST	O
(___):	O
FINDINGS:	O
There	O
is	O
no	O
evidence	O
of	O
acute	O
intracranial	B-Intracranial_haemorrhage
hemorrhage,	B-Intracranial_haemorrhage
midline	O
shift,	O
mass	O
effect,	O
or	O
acute	O
large	O
vascular	O
territorial	O
infarct.	O
Prominence	O
of	O
the	O
ventricles	O
and	O
sulci	O
is	O
consistent	O
with	O
atrophy.	O
Periventricular	O
and	O
subcortical	O
gray	O
matter	O
hypodensities	O
are	O
likely	O
sequelae	O
of	O
chronic	O
small	O
vessel	O
disease.	O
The	O
visualized	O
paranasal	O
sinuses	O
demonstrate	O
mucosal	O
thickening	O
of	O
the	O
ethmoid	O
air	O
cells	O
bilaterally.	O
There	O
is	O
minimal	O
mucosal	O
thickening	O
of	O
the	O
bilateral	O
sphenoid	O
sinuses.	O
Maxillary	O
sinuses	O
were	O
not	O
imaged.	O
There	O
is	O
minimal	O
mucosal	O
thickening	O
of	O
the	O
bilateral	O
frontal	O
sinuses.	O
The	O
mastoid	O
air	O
cells	O
are	O
clear.	O
No	O
acute	O
fracture	O
is	O
seen.	O
IMPRESSION:	O
No	O
acute	O
intracranial	O
process.	O
TTE	O
(___):	O
The	O
left	O
atrium	O
is	O
moderately	O
dilated.	O
The	O
left	O
atrium	O
is	O
dilated.	O
The	O
right	O
atrium	O
is	O
moderately	O
dilated.	O
Left	O
ventricular	O
wall	O
thickness,	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function	O
are	O
normal	O
(LVEF	O
>55%).	O
There	O
is	O
no	O
ventricular	O
septal	O
defect.	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
diameters	O
of	O
aorta	O
at	O
the	O
sinus,	O
ascending	O
and	O
arch	O
levels	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened.	O
Mild	O
(1+)	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
IMPRESSION:	O
Normal	O
regional	O
and	O
global	O
left	O
ventricular	O
systolic	O
function.	O
Increased	O
aortic	O
gradients	O
due	O
to	O
relatively	O
vigorous	O
LV	O
systolic	O
function,	O
mild	O
aortic	O
regurgitation	O
and	O
minimal	O
aortic	O
stenosis.	O
Mild	O
pulmonary	O
hypertension.	O
Brief	O
Hospital	O
Course:	O
___	O
with	O
h/o	O
dementia,	B-Dementia
HFpEF	O
and	O
CLL	O
who	O
presented	O
with	O
several	O
days	O
of	O
worsening	O
AMS,	B-Delirium
hypoxemia	O
and	O
cough,	O
subsequently	O
diagnosed	O
with	O
HFpEF	O
exacerbation.	O
#	O
HFpEF	O
Exacerbation:	O
Patient	O
presented	O
to	O
the	O
ED	O
with	O
history	O
of	O
cough	O
and	O
had	O
a	O
new	O
___	O
oxygen	O
requirement.	O
Creatinine	O
was	O
1.7	O
on	O
admission.	O
BNP	O
was	O
elevated	O
to	O
1631	O
without	O
any	O
prior	O
value	O
in	O
our	O
system	O
for	O
comparison.	O
He	O
carries	O
a	O
diagnosis	O
of	O
HFpEF	O
and	O
is	O
on	O
torsemide	O
as	O
an	O
outpatient.	O
CXR	O
was	O
without	O
frank	O
pulmonary	O
edema	O
or	O
consoidation,	O
although	O
there	O
was	O
mild-moderate	O
engorgement	O
of	O
the	O
pulmonary	O
ateries	O
suggestive	O
of	O
mild	O
volume	O
overload.	O
This	O
was	O
consistent	O
with	O
his	O
new	O
lower	O
extremity	O
1+	O
pitting	O
edema	O
bilaterally.	O
He	O
had	O
no	O
fever	O
or	O
sputum	O
production	O
suggestive	O
of	O
pneumonia.	B-Lower_respiratory_tract_infection
He	O
was	O
treated	O
empirically	O
for	O
HFpEF	O
exacerbation	O
with	O
IV	O
lasix	O
with	O
rapid	O
improvement	O
in	O
his	O
cough	O
and	O
O2	O
requirement	O
(weaned	O
to	O
room	O
air	O
by	O
___.	O
His	O
creatinine	O
downtrended	O
with	O
diuresis	O
to	O
1.2	O
on	O
day	O
of	O
discharge.	O
A	O
TTE	O
was	O
performed	O
on	O
___	O
which	O
revealed	O
no	O
significant	O
changes	O
from	O
his	O
prior	O
echo	O
(preserved	O
EF	O
>55%).	O
On	O
day	O
of	O
discharge	O
he	O
was	O
transitioned	O
to	O
an	O
increased	O
dose	O
of	O
torsemide	O
60mg	O
PO	O
qday.	O
Physical	O
therapy	O
recommended	O
discharge	O
to	O
rehab	O
facility	O
before	O
he	O
returns	O
home.	O
#	O
Toxic/metabolic	O
encephalopathy:	O
On	O
admission,	O
the	O
patient	O
was	O
somewhat	O
somnolent	O
(significantly	O
more	O
so	O
than	O
baseline	O
per	O
PCP	O
notes	O
and	O
discussion	O
with	O
his	O
daughter).	O
TSH	O
and	O
B12	O
levels	O
were	O
within	O
normal	O
limits.	O
The	O
primary	O
cause	O
of	O
his	O
altered	B-Delirium
mental	B-Delirium
status	B-Delirium
is	O
thought	O
to	O
have	O
been	O
delirium	B-Dementia
secondary	O
to	O
decompensated	O
heart	O
failure,	O
superimposed	O
on	O
the	O
patient's	O
baseline	O
dementia.	B-Dementia
His	O
mental	B-Delirium
status	B-Delirium
improved	O
significantly	O
with	O
treatment	O
of	O
his	O
heart	O
failure	O
decompensation.	O
Irrespective	O
of	O
the	O
patient's	O
substantial	O
improvement,	O
we	O
believe	O
he	O
would	O
benefit	O
from	O
a	O
higher	O
level	O
of	O
care	O
at	O
home	O
on	O
an	O
ongoing	O
basis.	O
These	O
concerns	O
were	O
discussed	O
with	O
the	O
patient,	O
his	O
daughter,	O
and	O
his	O
PCP	O
at	O
his	O
assisted	O
living	O
facility	O
who	O
will	O
make	O
the	O
necessary	O
adjustments	O
to	O
his	O
care	O
plan.	O
#	O
T2DM:	O
The	O
patient	O
pre-admission	O
medication	O
list	O
included	O
glyburide.	O
This	O
medication	O
is	O
particulary	O
dangerous	O
in	O
elderly	O
populations	O
and	O
with	O
this	O
patient	O
has	O
both	O
impaired	O
kidney	O
function	O
and	O
heart	O
failure,	O
both	O
of	O
which	O
significantly	O
impair	O
his	O
ability	O
to	O
clear	O
glyburide	O
and	O
glyburide	O
metabolites	O
from	O
his	O
body.	O
The	O
biologic	O
half-life	O
of	O
glyburide	O
is	O
thus	O
prolonged.	O
Furthermore,	O
given	O
the	O
patient's	O
advanced	O
age	O
and	O
co-existing	O
comorbidities,	O
it	O
seems	O
that	O
lenient	O
glycemic	O
control	O
would	O
likely	O
the	O
best	O
course	O
of	O
care.	O
The	O
patient's	O
glyburide	O
was	O
therefore	O
discontinued.	O
Since	O
his	O
A1c	O
this	O
admission	O
was	O
8.7%	O
and	O
his	O
sulfonylurea	O
was	O
discontinued,	O
his	O
home	O
metformin	O
XL	O
1000mg	O
qday	O
was	O
increased	O
to	O
short-acting	O
metformin	O
850mg	O
BID.	O
We	O
recommend	O
against	O
initiating	O
any	O
oral	O
hypoglycemic	O
agent	O
as	O
the	O
risk	O
of	O
hypoglycemia	O
outweighs	O
the	O
benefit	O
of	O
tight	O
glycemic	O
control	O
in	O
this	O
patient.	O
If	O
an	O
additional	O
agent	O
is	O
absolutely	O
required,	O
we	O
would	O
recommend	O
considering	O
a	O
small	O
once	O
daily	O
dose	O
of	O
Lantus	O
in	O
addition	O
to	O
his	O
metformin.	O
#	O
Anemia:	O
Hgb	O
~10	O
while	O
inpatient.	O
Unclear	O
baseline.	O
Iron	O
studies	O
consistent	O
with	O
iron	O
deficiency	O
anemia	O
with	O
superimposed	O
anemia	O
of	O
chronic	O
disease.	O
Ongoing	O
iron	O
supplementation	O
is	O
appropriate	O
as	O
long	O
as	O
this	O
is	O
tolerated	O
well	O
by	O
the	O
patient	O
and	O
does	O
not	O
precipitate	O
constipation.	B-Constipation
He	O
was	O
discharged	O
on	O
his	O
home	O
iron	O
regimen.	O
=====	O
TRANSITIONAL	O
ISSUES	O
=====	O
#	O
HFpEF:	O
-	O
Continue	O
torsemide	O
at	O
new	O
dose	O
of	O
60mg	O
PO	O
qday.	O
-	O
Please	O
weight	O
patient	O
daily.	O
If	O
patient	O
gains	O
more	O
than	O
3	O
lbs	O
from	O
his	O
discharge	O
weight	O
of	O
203.6	O
lbs,	O
please	O
increase	O
dose	O
of	O
torsemide	O
to	O
80mg	O
PO	O
qday	O
or	O
contact	O
his	O
primary	O
care	O
provider	O
for	O
further	O
instructions.	O
-	O
Please	O
check	O
Chem-10	O
on	O
___	O
and	O
send	O
result	O
to	O
his	O
PCP	O
(see	O
prescription	O
for	O
details).	O
#	O
T2DM:	O
-	O
Glyburide	O
was	O
discontinued	O
this	O
admission	O
due	O
to	O
concern	O
regarding	O
its	O
contribution	O
to	O
patient's	O
altered	B-Delirium
mental	B-Delirium
status	B-Delirium
as	O
well	O
as	O
questionable	O
safety	O
of	O
this	O
medication	O
in	O
the	O
setting	O
of	O
impaired	O
renal	O
function	O
(renally-cleared).	O
-	O
Metformin	O
XL	O
was	O
discontinued	O
and	O
replaced	O
with	O
short-acting	O
metformin	O
850mg	O
BID.	O
-	O
Recommend	O
against	O
starting	O
an	O
oral	O
hypoglycemic	O
agent	O
due	O
to	O
risk	O
of	O
hypoglycemia	O
and	O
limited	O
benefit	O
of	O
tight	O
glycemic	O
control	O
in	O
this	O
patient.	O
CODE:	O
Full	O
(confirmed)	O
EMERGENCY	O
CONTACT	O
HCP:	O
___	O
(daughter)	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
2.	O
Pravastatin	O
80	O
mg	O
PO	O
QPM	O
3.	O
Senna	O
8.6	O
mg	O
PO	O
QOD	O
PRN	O
constipation	B-Constipation
4.	O
Torsemide	O
40	O
mg	O
PO	O
DAILY	O
5.	O
Lisinopril	O
10	O
mg	O
PO	O
DAILY	O
6.	O
OLANZapine	O
2.5	O
mg	O
PO	O
QHS	O
7.	O
GlyBURIDE	O
7.5	O
mg	O
PO	O
DAILY	O
8.	O
MetFORMIN	O
XR	O
(Glucophage	O
XR)	O
1000	O
mg	O
PO	O
DAILY	O
9.	O
BuPROPion	O
(Sustained	O
Release)	O
150	O
mg	O
PO	O
QAM	O
10.	O
Citalopram	O
20	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
BuPROPion	O
(Sustained	O
Release)	O
150	O
mg	O
PO	O
QAM	O
2.	O
Citalopram	O
20	O
mg	O
PO	O
DAILY	O
3.	O
OLANZapine	O
2.5	O
mg	O
PO	O
QHS	O
4.	O
Pravastatin	O
80	O
mg	O
PO	O
QPM	O
5.	O
Senna	O
8.6	O
mg	O
PO	O
QOD	O
PRN	O
constipation	B-Constipation
6.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
7.	O
Torsemide	O
60	O
mg	O
PO	O
DAILY	O
8.	O
MetFORMIN	O
(Glucophage)	O
850	O
mg	O
PO	O
BID	O
9.	O
Outpatient	O
Lab	O
Work	O
Draw	O
Chem-10	O
on	O
___.	O
Indication:	O
ICD-9-CM	O
428.0	O
(CHF)	O
Send	O
result	O
to	O
Dr.	O
___:	O
___	O
10.	O
Lisinopril	O
10	O
mg	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Extended	B-Lives_in_carehome
Care	B-Lives_in_carehome
Facility:	B-Lives_in_carehome
___	O
Discharge	O
Diagnosis:	O
Primary	O
Diagnosis:	O
-	O
HFpEF	O
exacerbation	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Out	B-Mobile_with_assistance
of	B-Mobile_with_assistance
Bed	B-Mobile_with_assistance
with	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
to	B-Mobile_with_assistance
chair	B-Mobile_with_assistance
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
You	O
were	O
admitted	O
to	O
___	O
on	O
___	O
with	O
several	O
days	O
of	O
worsening	O
cough	O
and	O
altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
You	O
were	O
diagnosed	O
with	O
a	O
decompensation	O
of	O
your	O
congestive	O
heart	O
failure.	O
We	O
treated	O
you	O
with	O
diuretics	O
resulting	O
in	O
significant	O
improvement	O
in	O
your	O
symptoms.	O
During	O
your	O
stay	O
you	O
were	O
evaluated	O
by	O
physical	O
therapy	O
who	O
recommended	O
discharge	O
to	O
a	O
rehabilitation	O
facility	O
to	O
improve	O
your	O
strength	O
before	O
you	O
return	O
home.	O
It	O
was	O
a	O
pleasure	O
to	O
take	O
care	O
of	O
you	O
during	O
your	O
hospital	O
stay.	O
Sincerely,	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

